Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 studyDaniel R. Gomez, John V. Heymach, George R. Blumenschein et al.|The Lancet Oncology|2016Cited by 1.1k
Reirradiation of Head and Neck Cancers With Proton Therapy: Outcomes and AnalysesJack Phan, Steven J. Frank, William H. Morrison et al.|International Journal of Radiation Oncology*Biology*Physics|2016Cited by 149
Nivolumab for Patients With High-Risk Oral LeukoplakiaGlenn J. Hanna, Sook‐Bin Woo, Alessandro Villa et al.|JAMA Oncology|2023Cited by 56
Interferon Epsilon Loss Is Elusive 9p21 Link to Immune-Cold Tumors, Resistant to Immune Checkpoint Therapy, and Endogenous CXCL9/10 InductionXin Zhao, Scott M. Lippman, Bin Liu et al.|Journal of Thoracic Oncology|2024Cited by 12